Economist: Powell's Favorite Unconventional Inflation Gauge "Unreliable," Hopes for Challenge
BlockBeats News, June 16th, Federal Reserve Chairman Powell once expressed a preference for adopting another inflation measure standard - the "trimmed mean PCE inflation," which excludes extreme values before calculating the weighted average.
Boston College economics professor Brian Bethune stated that currently, the trimmed mean PCE is not the most reliable indicator. In short, when the inflation shock behaves similarly to the period of 2009-2019 (i.e., before the 2020 COVID-19 crisis), this indicator works best because there was a better balance between positive and negative shocks at that time. However, when price shocks mainly come from positive factors such as supply disruptions, tariffs, surging oil prices, or significant special sports events (like the World Cup), this indicator will underestimate inflation.
"Therefore, it is hoped that someone can challenge him on this," Bethune said. But regardless of which indicator is referenced, U.S. inflation remains above the Fed's 2% target - has been so since the spring of 2021.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Novavax Inc. Stock Slides 9.9%, Underperforms Peers
This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Novavax Inc. shed 9.9% to $11.32 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 27,599.79 and the Dow Jones Industrial Average rising 0.5% to 51,521.28. Novavax Inc. closed 15.4% below its 52-week high of $13.39, which the company achieved on October 5th. The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.7% to $254.78, Pfizer Inc. rose 0.3% to $27.50, and Merck & Co. Inc. rose 1.72% to $141.94. Trading volume totaled 19.3 million, compared to the 50-day average of 5.3 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 06, 2026 16:33 ET (20:33 GMT)
Evogene announces special shareholder meeting
Evogene will hold a special general meeting of shareholders in Rehovot, Israel on Nov. 10, 2026. Shareholders will vote on electing Oz Adler and Dr. Adi Zuloff-Shani to the board. Ballots will also cover the election of Itay Maroz and Shahar Zadok, subject to approval of a cooperation agreement. The meeting will also vote on a cooperation agreement between Evogene and L.I.A. Pure Capital and Invest-Pro Shukai Hon. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evogene Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-004722), on October 06, 2026, and is solely responsible for the information contained therein.
UK names 6 banks to lead first digitally native government bond
Altaris Completes Acquisition of Simulations Plus
02:57 PM EDT, 10/06/2026 (MT Newswires) -- Simulations Plus (SLP) said Tuesday that affiliates of Altaris have completed the acquisition of the company. The transaction price was $375 million, with each Simulations shareholder receiving $18.50 in cash per share, according to an earlier statement. As a result of the acquisition, Simulations said it has become a privately held company and its common stock will no longer trade on the Nasdaq Global Select Market.
Crypto prices
More
